{"id":"W4283780799","doi":"10.1016/j.annonc.2022.04.117","title":"P-26 HERIZON-GEA-01: A phase 3 study of zanidatamab in combination with chemotherapy with or without tislelizumab in first-line human epidermal growth factor receptor 2 positive (HER2+) advanced/metastatic gastroesophageal adenocarcinoma (GEA)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Zymeworks (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Trastuzumab; Antibody-dependent cell-mediated cytotoxicity; Chemotherapy; Cancer; Regimen; Cancer research; Oncology; Chemotherapy regimen; Combination chemotherapy; Internal medicine; Monoclonal antibody; Antibody; Immunology; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001057869,0.001203141,0.001912051,0.0004475993,0.0003932482,0.001229349,0.001052963,0.00118422,0.00515979],"category_scores_gemma":[0.0004614154,0.0006251512,0.001884735,0.0004154779,0.0009868767,0.0008699218,0.0003267749,0.004722056,0.001259788],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009665383,"about_ca_system_score_gemma":0.001571462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002073268,"about_ca_topic_score_gemma":0.007239276,"domain_scores_codex":[0.9997829,0.00007044319,0.000009003108,0.00003972001,0.00002165781,0.0000761865],"domain_scores_gemma":[0.9996914,0.00003756113,0.00004904192,0.00002241557,0.00002011115,0.0001793956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6024484,0.09781441,0.006466446,0.002528318,0.003859714,0.0004263742,0.0006630664,0.004752106,0.05957447,0.001054009,0.01118186,0.2092309],"study_design_scores_gemma":[0.6389216,0.3387541,0.0101575,0.0001029789,0.001175339,0.0003316716,0.0001477298,0.001426659,0.00371748,0.0002804469,0.004935953,0.00004850351],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869668,0.004274813,0.0005117903,0.0007974582,0.0002792611,0.002051366,0.001419839,0.0002016057,0.003496904],"genre_scores_gemma":[0.980992,0.005357996,0.001955166,0.001263802,0.0001548003,0.001797857,0.002644096,0.00006459827,0.005769599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00515979,"threshold_uncertainty_score":0.01726121,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0511468960694192,"score_gpt":0.3694295074956583,"score_spread":0.3182826114262391,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}